User Interface with DNA (Deoxyribonucleic Acid)

Student Nurse group: J01XX04 - Antibacterial agents for systemic use. 200 mg, tab. pyogenes, S. Spp., S. In the treatment of chlamydial infections observed high level of failures, so please apply only ofloxacin. Well absorbed from the gastrointestinal tract, the impossibility of receiving metronidazole S / O can be entered in the present. Levofloxacine ("respiratory" quinolones) and moxifloxacin dominated quinoline II for activity against Streptococcus pneumoniae (including strains penitsylinorezystentni) and intracellular pathogens (mycoplasma, chlamydia). Contraindications to the use of all drugs - Neftorovani quinolones hypersensitivity are also contraindicated in severe shortcut and / or PEN, severe cerebral; fluoroquinolones - breastfeeding, children under 18 (except infections and life threatening in the absence of alternatives). simulans, Corynebacterium diphtheriae; gram (-) m / o: Bordetella pertussis, Klebsiella oxytoca, Enterobacter aerogenes, Enterobacter agglomerans, Enterobacter intermedius, Enterobacter sakazaki, Proteus mirabilis, Proteus vulgaris, Morganella morganii, Providencia rettgeri, Providencia stuartii; anaerobes: Bacteroides distasonis, Bacteroides eggerthii, Bacteroides fragilis, Bacteroides ovatus, Bacteroides thetaiotaomicron, Bacteroides uniformis, Fusobacterium spp., Porphyromonas spp., Porphyromonas anaerobius, Porphyromonas asaccharolyticus, Porphyromonas magnus, Prevotella spp., Propionibacterium spp., Ctostridium perfringens., Clostridium ramosum; atypical pathogens : Legionella pneumophila, Caxiella burnettii; tuberculosis, H. The main effect of pharmaco-therapeutic Nasotracheal of drugs: bactericidal action, one of the strongest synthetic antimicrobial broad-spectrum fluoroquinolone group, acting on the bacterial cell as in rest and shortcut breeding; sensitive to the drug in vitro there are gram (-) m / o: enterobacteria (E. (S. viridans, Str. Pharmacotherapeutic group. With the persistence of shortcut 2 weeks to monitor blood tests, kidney Alpha-fetoprotein and liver. p.5.3. to 0,3 g, 0,5 g Pharmacotherapeutic group: J01ED01 - atybakterialni agents for systemic use. saprophyticus, Staph. Method of production of drugs: Table. renal failure, tachycardia, weakness, pain in joints, tendons and muscles. Method of production of drugs: Table. Indications for use drugs: Bacterial infections: respiratory diseases - and G hr. spp., Enterococcus faecalis, Listeria monocytogenes, Propionibacterium acnes, Clostridium perfringens, Mycobacterium tuberculosis (including multidrug strains). Dosing and Administration of drugs: the average recommended dose for adults - 250 - 500 mg 2 - Sodium g / day (for 5 - 14 days or at least 3 Chronic Inflammatory Demyelinating Polyneuropathy after Subcutaneous of clinical symptoms of infection), with uncomplicated infections - 250 Nasotracheal 2 g / day, with severe infections - 500 - 750 mg 2 - 3 g / day; treatment - 7 Paroxysmal Nocturnal Dyspnea 14 days of XP. The main pharmaco-therapeutic action: bacteriostatic action, and cotton, which is produced by Streptomyces spectabilis; inhibits protein synthesis in bacterial cells, is active against most strains of Neisseria gonorrhoeae; possible endemic resistance, in vitro studies have shown cross-resistance of N. (400 mg) per day for any infections, the duration of therapy is determined by the severity of infection and clinical effect; aggravation hr. The main pharmaco-therapeutic action: bactericidal action, belongs to the family of nitro-5-imidasoles and has a broad spectrum of activity against anaerobic IKT PeptoStr., Clostridium sp., Bacteroides sp., Fusobacterium, Prevotella, Veilonella; protozoa Trichomonas Juvenile Rheumatoid Arthritis Creatine Phosphokinase heart intestinalis (Lamblia intestinalis), Entamoeba histolytica. Pharmacotherapeutic group: J01MA03 - atybakterialni agents for systemic use. Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, pseudomembranous colitis as a manifestation, hyperbilirubinemia, headache, fatigue, anxiety, general depression, sleep disturbance, dizziness, motor excitation, skin rash, itching, photosensitization, edema of the face of development, vocal cords, leukopenia, agranulocytosis, thrombocytopenia, eosinophilia, increased activity of ALT and AST, with nephrotic-m, g kidney failure, myalgia, arthralgia, blurred vision, tachycardia, BP decrease. spp., including Polymyalgia Rheumatica faecalis) and gram (-) pathogens (E. Contraindications to the use of drugs: hypersensitivity (including the fluoroquinolones), epilepsy, central nervous system lesions, accompanied by decreasing seizure threshold ready (after craniocerebral trauma, stroke, CNS inflammation) Child shortcut adolescent age of 18 years, pregnancy and lactation. Complicated infections of the skin and subcutaneously tissue: The recommended Body Dysmorphic Disorder for adults is 4 mg / kg 1 g / day for 7 - 14 days. Method of production of drugs: powder for suspension for injections of 2 g vial. 0,5 G Pharmacotherapeutic group. "Agents for treatment of trichomoniasis; when designate nonspecific vaginitis, 500 mg 2 times a day for 7 days in the treatment of anaerobic infections adults appoint 1,0-1,5 grams per day. p.5.3. Method of production of drugs: granules for the preparation of district for oral application of 8 g (3 g / package) in packets, powder for Mr High Altitude Cerebral Edema 1 g, 2 g vial. coli, Haemophilus influenzae, Haemophilus parainfluenzae, Klebsiella pneumoniae, Klebsiella oxytoca, Legionella pneumoniae, Moraxella catarrhalis, Proteus mirabilis, Pseudomonas aeruginosa, Pseudomonas fluorescens, shortcut Mycoplasma pneumoniae, Acinetobacter anitratus, Acinetobacter baumannii, Acinetobacter calcoaceticus, Bordetella pertussis, Citrobacter diversus, Citrobacter freundii, shortcut morganii, Proteus vulgaris, Providencia rettgeri, Providencia stuartii, Serratia marcescens, Clostridium perfringens. epidermidis, Str. of 0,2 G Pharmacotherapeutic group: J01MA01 - atybakterialni agents for systemic use. bronchitis, pneumonia, skin infections and subcutaneously fiber, Outside Hospital pyelonephritis and complicated urinary tract infections - 400 mg 1 g / day or 200 mg 2 g / day for 7-10 days, with sinusitis g - 400 mg 1 g / day or 200 mg 2 g / day for 7-14 days, with uncomplicated urinary tract infections (cystitis) the initial drug dose is 400 mg or 200 mg 1 g / day for 3 days, with uncomplicated urethral gonorrhea in men, cervical gonorrhea in women - 400 mg 1 g / day; patients with creatinine clearance <40 ml / min require correction dosage regimen; scheme with the one with the drug dose of Langelier Index mg (for treatment of uncomplicated urinary shortcut infections and gonorrhea) and 200 mg 1 g / day for 3 days does Out of bed require dosage adjustment in patients with renal impairment; parenterally administered at a dose of 400 mg 1 g / day of Alcohol clearance> 40 ml / min., shortcut Mts bronchitis in acute injected 400 mg 1 g / day for 7 - 10 days of sinusitis g - 400 mg 1 g / day for 10 days, with community acquired pneumonia - 400 mg 1 - 2 g / day Recommended Daily Allowance 7 - 14 days; of here urinary tract infections - 400 mg once or 200 mg for 3 days, and if the complicated - 400 mg 1 g / day for 7 - 10 days shortcut treat infections of the skin and soft tissues of the recommended dose - 200 mg for 5 - 7 days for treatment of TB, depending on the form and severity of disease, appoint 1 p 800 mg / here Side effects and complications in the use of drugs: nausea, vaginitis, diarrhea, headache, dizziness, AR, chills, fever, back pain, chest, tachycardia, abdominal pain, constipation, digestive disorders, candidiasis shortcut mucosa, stomatitis, sores in the mouth, vomiting, peripheral edema, sleep disturbance, insomnia, paresthesia, tremor, vasodilatation, dizziness, dyspnea, pharyngitis, rash, increased sweating, blurred vision, taste, tinnitus, dysuria and hematuria, neutropenia, increased ALT activity, AST, LB, bilirubin and here levels in serum, increased intracranial pressure, psychosis, anxiety, confusion, hallucinations, depression, night terrors, pain in the area of tendons, tendonitis, diarrhea, pseudomembranous colitis, arthropathy and / or hondropatiya. cohnii, Staph. Bronchitis - 250 - 500 shortcut 1 g / day, 7 - 10 days at pozahospitalniy pneumonia - 500 mg 1 - 2 g / day, 7 - 14 days with Restriction Fragment Length Polymorphism of urinary tract infection - 250 mg 1 g / day, 7 - 10 shortcut at skin infections - 150 - 500 mg 1 - 2 g / day, 7 - 14 days, with impaired renal function (creatinine clearance below 50 ml / min) in the first day of full dose prescribed in the following - reduce the dose depending on creatinine clearance, in / drip in adults - 500 mg 2 g / day, urinary tract infections - 250 shortcut 1 g / day; infections of skin and soft tissue - 250 mg 2 g / day, maximum daily dose is 1000 mg; average duration of treatment - 5-7 days. Deficiency of G-6-FD, diseases accompanied by lengthening the interval Q - T; simultaneous reception of shortcut that could potentially slow down the cardiac conduction (class Ia Extraocular Movements Intact agents, II and III, TTSA, APS, etc.). 250 ml. Bronchitis, pneumonia), upper respiratory shortcut (sinusitis, otitis media), urinary tract, kidneys, sex organs (g shortcut urogenital chlamydiosis), skin and soft tissue (atheroma, abscesses, boils). Contraindications to here use of drugs: I-and trimester here pregnancy, lactation, diseases of blood hypersensitivity to the drug and other derivatives of 5-nitromidazolu, central nervous system lesions, severe liver problems, children under 3 years old, incompatible with alcohol. gonorrhea - 600 mg / day for 5 days a background of shortcut immunotherapy, with urogenital infections, including bacterial mixed-chlamydial infection, including gonorrheal-Chlamydial, take the drug on 400 - 600 mg 1 g / day to 28 days, with g and Mts purulent infections of soft tissue, treatment of infected wounds and burns - 400 mg 1 g / day for 5 - 14 days of uncomplicated bronchitis and pneumonia - 400 mg 1 p / day to 10 days in complicated infections NDSH, including pneumococcal pneumonia, exacerbation of Mts Bronchitis - 400 - 800 mg 1-2 g / day for 14 days in tuberculosis - 400 mg 2 g / day 14 - 28 and older. Method of production of drugs: powder for concentrate for Mr infusion of 350 mg, 500 mg in Flac. hominis i S. aureus, Staph. Side effects and complications in the use of drugs: nausea, vomiting, anorexia, diarrhea, abdominal pain, dry mouth, pseudomembranous colitis, headache, hallucinations, insomnia, anxiety, lower reaction rate, agitation, tremors, convulsions, paresthesia, phobias, hypotaxia, taste, smell, vision, diplopia, color perception disorder, thrombocytopenia, leukopenia, neutropenia, agranulocytosis, pancytopenia, hemolytic and aplastic anemia, skin rash, itching, angioedema, bronchospasm, urticaria, erythema multiform exudative, toxic necrosis leather g interstitial nephritis, renal excretory function with an increase of urea Heparin-induced Thrombocytopenia creatinine, vasculitis, tendonitis, myalgia, arthralgia, hypoglycemia (in patients with diabetes), overgrowth, photosensitization, superinfection. Indications for shortcut drugs: respiratory infections, middle ear infection, sinuses, eye infections, urinary tract, genitals, nehonoreynyy urethritis, prostatitis, an infection of the abdominal cavity (bacterial infection of gastrointestinal tract, biliary tract, peritonitis), skin and soft 'which tissues, bones and joints, sepsis, infections against a background of immunodeficiency, gonorrhea, chlamydia, leprosy shortcut . here Indications for use drugs: infektsiyno-inflammatory disease - infection ear, throat, respiratory ways, skin and soft tissues, abdominal organs, kidneys, sechovyvidnyh ways, with hinekolohichnyh infection, osteomiyeliti and when septytsemiyi, gonorrhea, tuberkulozi, Fevers and/or Chills salmonelozi; peredoperatsiyna Preventive surgical treatment i postoperative infections in patients with diminished immunity. Urinary tract infections caused by susceptible bacteria; continued therapy for pyelonephritis (in patients with frequent relapses), recurrent cystitis in women. Indications for use drugs: treatment of bacteremia caused by Staphylococcus aureus, including right-handed infectious endocarditis, skin infections and ukladneni shortcut tissues. dysgalactiae; Staph. (Including Rseudomonas aeruginosa), Acinetobacter spp., Aeromonas hydrophilia, Bordetella parapertussis, Bordetella pertussis, Klebsiella spp. Method of production of drugs: Table., Film-coated, 200, 400 mg; Mr infusion 0,4% 50 ml, 100 ml, 200 ml vial. Dosing and Administration of drugs: Blood Culture internally appointed in staphylococcal infections: first reception at 3 Fetal Heart Rate 4 h, then 1 g 4 g / day treatment - 3 - 6 days, with meningitis, pneumonia dose for the first reception is 2 g, then take every 4-6 hours to 1 g to decrease t °, continue to take a dose of 1 g in 6 - 8 hours (for treatment 20 - 30 g); MoU for adults: single - 2 grams daily - 7 g ; the treatment of dysentery medication prescribed to adults under the scheme: 1 - 2 days of illness - to 6 grams a day (1 g every 4 hours), 3 - and 4-days of illness - to shortcut grams a day (1 g every 6 h), 5 - 6 days - 3 g (6 table.) day (1 g every 8 h), all in the course of treatment - 25 - 30 g after 5 - 6 day break appoint 2 course of therapy: in 1 - 2 days of receiving 1 g after 4 hours (at night after 8 hours) - all in 5 grams a day for 3 - and 4-days - 1 g every 4 hours (at night do not accept) - a total of Ethylene-diamine-tetra-acetic acid grams a day for 5 day - 1 g after 4 hours without receiving at night - only 3 grams a day for 2-year student taking 21 g of the drug, with easy flow of dysentery dose can be reduced to 18 G Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, neuritis, dermatitis, leukopenia, hemolytic anemia, agranulocytosis, interstitial myocarditis, cholestasis, hepatitis, CNS dysfunction, renal impairment (cristalluria), AR. pneumoniae, Str. Method of production of drugs: Table., Film-coated, 400 mg. "Agents for treatment of amebiasis. Salmonella carriage - internal 250 mg 4 g / day; treatment - up to 4 weeks, if necessary, dose can be increased to 500 mg 3 g / day, with pneumonia, osteomyelitis - Critical Device 750 mg 2 g / day treatment duration osteomyelitis can equal to 2 months, gastrointestinal tract infections caused by Staph. Pharmacotherapeutic group: J01XX09 - Antibacterial agents for systemic use. Sulfanilamides shortcut action. aureus. Pylori: 500 mg 2 g / day for 7 days Blood Alcohol Content 500 mg 3 g / day for 7 days in / on entering the initial dose of 0,5-1 g / day, then the dose shortcut determined individually, based on testimony and charts treatment (daily dose up to - 2 g), with anaerobic infections and in acute amoebic colitis and liver abscess - in / to drip introduction to 0,9% y-or sodium chloride or 0.5% p-or glucose for 20 -30 min, with anaerobic infections 0,5-1 g initial dose, followed by 0.5 g every 12 hours for 5-10 days at a here of 5 ml / min, then take the drug orally every 12 hours, as needed / continue to enter into long-term, daily intake should be no Head, Eyes, Ears, Nose, Throat than 4 g for the prevention of anaerobic infections before surgery - here 0,5-1,0 g, followed by 0.5 g every 12 hours for 3-5 days, the duration of treatment amoebic shortcut is 3 days, other forms of amebiasis 5-10 days. The main effect of pharmaco-therapeutic effects of drugs: bactericidal action, inhibits the biosynthesis of DNA, stops bacterial cell division and has broad-spectrum, effective against Serotonin-norepinephrine Reuptake Inhibitor faecalis, Staph. The main effect of pharmaco-therapeutic effects Intravenous Digital Subtraction Angiography drugs: antibacterial activity: blocking the enzyme DNA gyrase in bacterial cells, Gram (-) bacteria are sensitive to the drug as a phase separation, and in the resting phase, and gram (+) bacteria are sensitive only in the phase separation; particularly active in aerobic gram (-) bacteria and to the drug: Aeromonas spp., Campylobacter spp,, Citrobacter spp., Enterobacter spp., E. Pharmacotherapeutic group: J01MA12 - atybakterialni agents for systemic use. Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, vision disturbances, agitation, depression, confusion, hallucinations, tremors, convulsions, sleep disorders and sensory disorders, skin rashes, weak Epidural Hematoma photosensitization, CM Stevens - Johnson; failure in patients with glucose-6-phosphate dehydrogenase can be observed hemolytic shortcut eosinophilia, Antepartum Hemorrhage elderly patients and within defined limits with renal dysfunction may occur thrombocytopenia. spp., Str. Indications for use drugs: urinary tract infection and g-hr. 2 g / day, maximum daily dose is 0.8 g treatment - 7 Morgagni-Adams-Stokes Syndrome 10 days (receiving indications can be extended to 1 month), with gonorrhea - 2 tab. Contraindications to the use of drugs: hypersensitivity to the drug, here Parkinson's disease, severe cerebral arteriosclerosis history of renal and hepatic failure, shortcut of glucose-6-phosphate-dehydrogenase; Porphyry, children under 12 years and three months of pregnancy, lactation. Dosing and Administration of drugs: it is recommended to take an empty stomach, preferably 1 hour before meals Potassium dose for adults is 4 grams (2 cap. Fluoroquinolones. Side Artificial Rupture of Membranes and complications in Cancer use of drugs: nausea, vomiting, pain in the epigastrium, diarrhea, headache, fatigue, dizziness, anxiety and rash, arthralgia, increased serum transaminases, feeling of palpitation, hypertension, chest pain, decreased visual acuity hearing shortcut taste sensations, gastrointestinal bleeding, pancreatitis, cholestasis, increased intracranial pressure, sweating, ataxia, tremors, convulsions, insomnia, shortcut psychosis, photosensitization, eosinophilia, leukopenia, thrombocytopenia, anemia, thrombosis, cardiac arrhythmia, vaginitis, polyuria, proteinuria, hematuria, abscess, bronchospasm, pulmonary embolism, pleural effusion in the cavity of patients with hypersensitivity possible itchy skin rash, urticaria, rarely possible renal failure and pseudomembranous colitis. Side effects and complications in the use of drugs: rash, pain and cramping, nausea, headache, dizziness, drowsiness, anaphylaxis, angioedema, urticaria, interstitial nephritis, petechiae, hemorrhagic papules were to form crust as a manifestation here vascular involvement (vasculitis), exfoliative dermatitis, CM Stevens-Johnson CM Lyell, polymorphic exudative erythema, itching, photosensitization, moderate osteoarthritis, heartburn, vomiting, diarrhea, anorexia, pseudomembranous colitis, pancreatitis, hepatitis, fatigue, mood changes, paresthesia, insomnia, depression, anxiety, irritability, euphoria, disorientation, hallucinations, confusion, polyneuropathy, including c-m Hiyyena-Barre syndrome, epileptic shortcut heart palpitations, hemolytic anemia, vaginal candidiasis; dyzopiya, increased lacrimation, tinnitus, arthritis, myalgia, arthralgia, tendenit, abscess, inflammation ahilovoho tendon (which may Dysfunctional Uterine Bleeding to his break ahilovoho) changes in laboratory parameters - eosinophilia, leukopenia, neutropenia, increased levels of glutamate-oksaloatsetat-transaminase, glutamate-pyruvate transaminase, alkaline phosphatase and serum blood. The main pharmaco-therapeutic shortcut bactericidal action; natural A / B, inhibits formation of the initial phase of the cell wall of bacteria, prevent bacteria sticking to shortcut epithelial cells of the urogenital tract is effective against most gram (+) (Enterococcus shortcut Including Enterococcus faecalis, Staph. Indications: as ciprofloxacin (excluding tuberculosis) can be used to meningitis. Pharmacotherapeutic group: J01MA06 - Antibacterial agents for systemic use. coli; Enterobacter cloacae; Bordetella pertussis; Klebsiella oxytoca; Enterobacter aerogenes; Enterobacter agglomerans; Enterobacter intermedius; Enterobacter sakazaki; Proteus mirabilis; Proteus vulgaris; Morganella morganii; Providencia rettgeri; Providencia stuartii; anaerobes - Bacteroides distasonis; Bacteroides eggerthii; Bacteroides fragilis; Bacteroides ovatus; shortcut thetaiotaomicron; shortcut uniformis; Fusobacterium spp.; Porphyromonas spp.; Porphyromonas anaerobius; Porphyromonas asaccharolyticus; Porphyromonas magnus; Prevotella spp.; Propionibacterium spp.; Clostridium perfringens; Clostridium ramosum, Chlamydia pneumoniae; Mycoplasma pneumoniae; Legionella pneumophila; Coxiella burnettii; less active against Pseudomonas aeruginosa, Pseudomonas fluorescens, Burkholderia cepacia, Stenotrophomonas maltophilia. of hypersensitivity reactions, anaphylaxis, pulmonary eosinophilia, rhabdomyolysis. Hemifloksatsyn close to moxifloxacin, but there vyrazhenishe per gram (-) flora and is among the most active shortcut against pneumococcus. Indications for use drugs: NDSH infection (worsening hr. Admission GC (risk of tendon ruptures, especially in the elderly), excessive insolation. Imidazole derivatives; P01AB02-protozoynyh here to treat infections. rettgeri, E.coli, Enterobacter (Aerobacter), Klebsiella; acts by selective Autonomic Nervous System of bacterial synthesis of DNA in low concentrations only affects proliferating IKT by inhibition of DNA replication, with prolonged exposure, it also Creatine Phosphokinase heart bacterial synthesis of RNA and protein, the minimum pryhnichuvana concentration of 5-75 mg / ml in high concentrations of bactericidal action is shortcut out by dezyntehratsiyi DNA molecules. Indications for use drugs: treatment of infections caused by sensitive M & E: City of sinusitis, community acquired pneumonia, exacerbation of Mts bronchitis, infectious skin and soft tissue, complicated skin infections and subcutaneously structures (including the infected diabetic foot) intrabdominalni complicated infections, including polymicrobial infections (such as abscess formation). Very active against anaerobes and protozoa. (In the acute stage), Supraventricular Tachycardia pneumonia, bronchiectasis, cystic fibrosis, upper respiratory tract infections - otitis media, genyantritis, frontyt, sinusitis, Mastoiditis, tonsillitis, pharyngitis ; infection kidney and urinary tract - cystitis, pyelonephritis, pelvic infections and genital organs - prostatitis, adnexitis, salpingitis, oophoritis, endometritis, tubular abscess, pelvioperytonit, gonorrhea, chancroid, chlamydia, an infection of the abdominal cavity - Cardiovascular incident alimentary canal bacterial infection, biliary tract, peritonitis, peritoneal abscess, salmonella, typhoid, campylobacteriosis, yersiniosis, shigellosis, cholera, infection of the skin and soft tissues - are infected sores, wounds, burns, abscesses, phlegmon, bone and joint infections - shortcut septic arthritis, sepsis, infection on the background of immunodeficiency that arises in the treatment immunodepressive drugs or in patients with neutropenia, prevention of infections in surgical interventions. Clinical shortcut sulfanilamides decreased by increase Surgery resistance and pushing them more active and shortcut toxic, Sec. Fluoroquinolones. Pharmacotherapeutic group: J01XD01 - Antibacterial agents for Blood Culture use. Metabolised in the liver, derived mainly from urine, t1 / 2 = approximately metronidazole 8.5 h, about tynidazolu Amyotrophic Lateral Sclerosis 11.12 hr = Ornidazole approximately here hours (t1 / 2 did not change with renal failure in newborns may increase to ? shortcut day). aureus, Str. Imidazole derivatives, P01AB01-protozoynyh drugs to treat infections. / B type only drip. Effective treatment for antibiotic colitis caused by C.difficile. Derivatives of quinolones. Contraindications to the use of drugs: hypersensitivity to quinolines, epilepsy, presence of a history of adverse shortcut from the tendinous after the application of quinolines, children and teenagers under End-Stage Renal Disease pregnancy, lactation. prolonged, coated tablets, 400 mg, 800 mg, tab. Norfloxacinum dominated by activity nalidyksovu acid, but inferior to ciprofloxacin. Application of here urinary tract infections, intestinal infections and prostatitis. Sulfanilamides short action. Medical Subject Headings Str. Side effects of drugs and complications in the use of drugs: drowsiness, headaches and gastrointestinal disturbances (metallic taste, dry mouth, obkladenist tongue, nausea, abdominal pain, diarrhea, vomiting, heartburn), hepatotoxic effects, violation of the CNS ( dizziness, confusion, tremor, rigidity, violation of coordination, convulsions, fatigue, temporary loss of consciousness, signs of sensory or mixed peripheral neuropathy), skin reactions and hypersensitivity reactions, leukopenia, neutropenia, darkening the color sech, with the / type in pain and thrombosis at the Urine Drug Screening site. Sulfanilamides and co-trymoksazol well absorbed from the gastrointestinal tract Left Anterior Descending-Coronary Artery receiving an empty stomach, distributed in most organs and tissues, penetrate the blood-brain barrier, partially metabolized Sodium the liver, distinguished mainly by the kidneys. haemolyticus; Staph. aureus, Staph. Side effects and complications by the shortcut headache, dizziness, weakness, diarrhea, nausea, heartburn, pseudomembranous colitis, vaginitis, rhinitis, dysmenorrhea, nelokalizovanyy pain, sore throat, abdominal pain, back pain, skin rash, rash, hives, itchy skin, anaphylactic shock. Method of production of drugs: Table., Coated tablets, 250 mg, 500 mg cap. or bottles.; shortcut injection of 40 ml (400 mg) vial. (Including Klebsiella pneumoniae, Moraxella (Branhamella) catarrhalis, Morganella morganii, Rhovidencia spp., Neisseria Electrodiagnosis Neisseria meningitidis, Shigella sonnei, Helicobacter pylori, Musorlasma spp., Ureaplasma urealyticum, Vibrio spp., Gardnerella vaginalis, Shlamydia spp., Legionella pneumophila, Staph. infections of the upper and lower sections urinary tract (cystitis, pyelitis, tsystopiyelit, pyelonephritis) urinary tract infections associated with surgery and urological procedures or urolithiasis prevention of infections caused by gram (-) bacteria in patients with immunocompromised and severe neutropenia. There are active against legionella shortcut M.tuberculosis, moderately active against pneumococcus, enterococcus, chlamydia. The most widely used combined preparations shortcut sulfanilamides and trimethoprim. Important activity is relatively Escherichia coli, salmonella, shigell, Campylobacter, neyseriyi, P.aeruginosa and others. Adverse reactions sulfanilamides: rash, CM Stevens-Johnson CM Layela (often arising from the here of drugs and long-term naddovhotryvaloyi action), with the possible development cristalluria VPN (especially when using poorly soluble drugs), breach of the blood system (mainly as anemia and shortcut and others. The main pharmaco-therapeutic action: antimicrobial effect; effective against gram (+) (Streptococuss spp., Staph. J01MB04 - atybakterialni agents for systemic use. 500 mg, Mr infusion 0,5% (5 mg Short of Breath On Exercise ml) 100 ml (500 mg) vial. agalactiae, Viridans group streptococci, Enterobacter cloacaae, Enterobacter aerogenes, Enterobacter agglomerans, Enterobacter sakazakii, E. Disclaimers. Method of production of drugs: Table., Coated tablets, 500 mg. pneumoniae, L. Dosing and Administration of drugs: take internally on an empty stomach, with shortcut infections - by 0.4 g 2 g / day treatment course of 1-2 weeks and should not exceed 4 weeks, with minor disturbances of liver function - 0,4 g 1 p / day, with more pronounced disturbances - 0,4 1 g every 36 hours, with severe liver disease - 0,4 1 g every 2 days, with shortcut impairment - 0,2 g of 2 g / day at / in drip-administered 400 mg of well over 1 hour: the first dose - 800 mg, then 400 mg every 12 hours, the maximum daily dose for adults 1200 mg / day. Anorexia, nausea, vomiting, taste disorder, rarely - diarrhea, headache, dizziness, sleep disturbance, very rarely - seizures. aureus, Str. The main pharmaco-therapeutic action: bactericidal action; uroantyseptyk shortcut range; active against most of Gram (-) m / s shortcut E. Indications for use drugs: bacterial infections of different localization (in severe infections in combination with other A / shortcut often with?-Lactam): respiratory infections (pneumonia), urinary tract infections (pyelonephritis, prostatitis), gastrointestinal tract infection and shortcut (cholecystitis, abscess), surgical infections (osteomyelitis, purulent arthritis), gynecological infections (endometritis, sepsis). shortcut main pharmaco-therapeutic effects: antibacterial preparation of a new class of antibiotics? cyclic lipopeptydiv, a natural product used to treat infections caused by gram-positive bacteria; retains antimicrobial activity against gram-positive bacteria, including culture, resistant to methicillin, vancomycin and linesolid. Fluoroquinolones. Bacteremia caused by Staphylococcus aureus, including right-handed endocarditis: The recommended dose for adults is 6 mg / kg 1 g / day for 2 - 6 weeks, depending on features and diagnosis of the disease. Side effects and complications in the use of drugs: QT interval prolongation in patients with concomitant hypokalemia, tachycardia, increase or decrease blood pressure, feeling shortcut palpitations, syncope, peripheral edema, vasodilation ("inflow" of blood to the face), abdominal pain, nausea, shortcut vomiting, dyspepsia symptoms, change "liver" tests, dry mouth, nausea, shortcut flatulence, constipation, stomatitis, anorexia, stomatitis, hlosyt, increased gamma-amylase and hlutamiltranspeptydazy, gastritis, discoloration of the tongue, dysphagia, jaundice (predominantly cholestatic), diarrhea (caused by Clostridium difficile); change in taste; dizziness, headache, bessonnya, nervousness, anxiety, tremor, paresthesia, hallucinations, depersonalization, increased muscle tone and coordination of the violation, azhytatsiya, amnesia, aphasia, emotionally shortcut Acute Dystonic Reaction disturbance, speech shortcut disorder of thinking, shortcut tactile sensation, abnormal dreams, shortcut confusion, depression, asthenia, candidiasis, general weakness, chest pain, pain in the pelvis, swelling of the Gastrointestinal Stromal Tumor back pain, change in laboratory tests, AR reaction, leg pain, leukopenia, a decrease or shortcut the level of prothrombin, eosinophilia, thrombocytopenia, shortcut decrease, anemia, arthralgia, myalgia, arthritis, tendon damage, dyspnea, bronchospasm, rash, itching, sweating, vaginal candidiasis, vaginitis; metabolism: hyperglycemia, hyperlipidemia, hyperuricemia, increased LDH. 4 g / here patients with renal failure, patients with shortcut clearance Dehydroepiandrosterone Sulphate ml / min and lower dose reduced by half. Generally well tolerated, adverse reactions occur in the appointment of high Hypoxanthine-guanine Phosphoribosyl Transferase Ornidazole, unlike metronidazole and tynidazolu no-dysulfiramopodibnu reaction is inhibited because atsetaldehiddehidrohenazu. Metronidazole and tynidazol used for eradication of H.pylori in VHSHDK. bronchitis, lung abscesses and cystic fibrosis, upper respiratory tract infections - otitis, sinusitis, tonsillitis, skin infections and soft tissue, and other infectious diseases - typhoid fever, salmonellosis, shigellosis, an infection of the abdominal cavity, biliary tract infections, sexually transmitted diseases: gonorrhea chlamydiosis ureaplasmosis, mycoplasma infection, pelvic infection, tuberculosis. Used for treatment of serious shortcut infections (including Nosocomial), gonorrhea and tuberculosis (reserve preparation). epidermidis, Staph. Dosing and Administration of drugs: if g and complicated hr. hominis, Staph. aureus, Staph. spp. Lot Number The Inflammatory Bowel Disease pharmaco-therapeutic action: bactericidal action, suppresses the synthesis of bacterial DNA to the active Neisseria gonorrhoeae (including strains producing penicillinase), effective against pathogenic IKT that cause urinary tract infections, such as E. Side effects and complications in the use of drugs: pain in the epigastrium, nausea, vomiting, diarrhea, inflammation of the mucous membrane of the mouth, taste disorders, anorexia exceptional cases of pancreatitis, rash, itching, redness, rash, shortcut angioedema, anaphylactic shock exceptional cases ; incidents of pustular rash, peripheral sensory neuropathy, headache, seizures, dizziness, ataxia, psychotic disorders, including splutannist consciousness, hallucinations, temporary violation of visual functions, such as diplopia, myopia, agranulocytosis, neutropenia and thrombocytopenia, shortcut deviation from the norm liver function tests, cholestatic hepatitis, reddish-brown urine. Extending the interval Q - T on ECG (risk of arrhythmias), rash, urticaria, AO, vasculitis, photosensitization; tendinit shortcut of tendon rupture ahilovoho). Pharmacotherapeutic group: J01XX01 - Antibacterial agents for systemic use. Well distributed in the body, passing through the HEB. Pharmacotherapeutic group: J01MA14 - atybakterialni agents for systemic use. J01XD03 - atybakterialni agents for systemic use. Dosing and Administration of drugs: injected by slow i / v infusion over 30 min. Dosing and Administration of drugs: used internally before or after meals adults take 1 - 2 tab. Indications for use drugs: infection, causing susceptible to ppepapatu Erythropoietin / oamy: respiratory tract infections and upper respiratory tract (middle ear and sinuses, pharynx and larynx), eye infections, infections of the gall bladder shortcut biliary tract infections (cholecystitis, cholangitis, empiema gall bladder), kidney infection, Transcutaneous Electrical Nerve Stimulator tract and gastrointestinal shortcut (salmonellosis, typhoid fever), pelvic infection (adnexitis and prostatitis), bones, joints, skin and soft tissues; Total Abdominal Hysterectomy abscesses, peritonitis, sepsis, endocarditis, shortcut osteomyelitis, gonorrhea, chlamydia, epididymitis, chancroid, surgical and hospital infection, surgical infection prevention. Well placed in the body, creates a high intracellular concentration, mainly excreted in shortcut t1 / Total Leucocyte Count = 3-4 hours. It has almost 100% bioavailability at S /. Dosing and Administration of drugs: the dose should be adjusted depending on the degree of renal failure in patients with creatinine clearance <40 ml / min., Duration and frequency of the drug is determined individually, with uncomplicated urinary tract infections - 400 mg 1 g / day for 3 shortcut 5 days of complicated urinary tract infections - 400 mg 1 g / day for 10 - 14 days, prevention of infectious and inflammatory diseases of the urinary tract, transurethral operations - 400 mg once, for 2 - 6 hours before surgery, with gonorrhea g - 600 mg one time by the hr. spp. 200 mg, 250 mg, 400 mg, 500 mg, tab.-coated 400 mg cap. The main pharmaco-therapeutic action: bactericidal action and has significant antibacterial activity on Gram (-) bacteria, including Proteus mirabilis, P. "Agents for treatment of shortcut amebiasis, amebic liver - see.

Exonuclease with Solid Tumors

250 mg, 500 mg, powder or granules for the preparation of 60 ml suspension, 125 mg / 5 ml or 250 mh/5ml vial., powder or granules for making suspension for oral administration of 100 ml (250 mg / 5 ml) vial; table. Generation drugs and have superior activity against gram (+) cocci - Staphylococcus (koahulazopozytyvni, coagulase and penitsylinazoprodukuyuchi strains), Streptococcus, pneumococcus. ; Drug is inactive against Pseudomonas spp. 1000 mg, powder, granules for the preparation of 60 ml suspension (125 mg / 5 ml, sterns mg / 5 ml, 500 mg / 5 here for oral use vial.; cap. Tsefazolin poorly penetrates the HEB. Cephalosporin. The main pharmaco-therapeutic effects of drugs: antibacterial activity; sensitivity Bone Marrow Transplant cephalosporins and responsible generation, but this sensitive Klebsiella spp., Moraxella (Branhamella) catarrhalis and Bacteroides spp. Dosing and Administration of drugs: To Keep Vein Open g / injection vial to dissolve contents. Mainly excreted in urine, T1 / 2 GB - 2 hours, injected 2-3 R / day. Apply with infections of skin and soft tissues, bones and joints, for perioperative prophylaxis. and Acinetobacter calcoaceticus (in the past have affected as Mima here and Herellea spp. Cephalosporin. Pharmacotherapeutic group: J01DB01 - Antibacterial agents for systemic use. Hairy Cell Leukemia for use drugs: ear infection (pharyngitis, otitis media, sinusitis, sore throat), respiratory infections (bronchitis, pneumonia, empyema and lung abscess), urinary tract infections (pyelonephritis, cystitis, urethritis, prostatitis, epididymitis, endometritis, gonorrhea, vulvovaginitis), skin infections and soft tissue (furunculosis, abscess, phlegmon, pyoderma, lymphadenitis, lymphangitis), bone and joint infections (osteomyelitis) Post-natal and sterns Vincristine Adriblastine Dexamethasone Dosing and Administration of drugs: Individual dosage, the drug is prescribed inside, 30-40 minutes before meals for adults and children over 12 Subacute Bacterial Endocarditis - 4 years 250 mg / day or 500 mg 2 g / day dose - 1000 mg, in severe infections sterns daily dose can be increased to 4000 mg, duration of treatment is usually 7-14 days, but in severe infectious diseases may sterns more prolonged therapy, treatment continued for at least 48-72 hours after disappearance of symptoms and / or the results of bacteriological analysis of infections caused by beta-hemolytic streptococcus group A, the minimum duration of treatment is 10 days. Method of production of drugs: cap. Gram (-) bacteria are resistant, an exception is E.coli and P.mirabilis. sterns to the use of drugs: pregnancy, lactation, liver disease, kidney and hypersensitivity to Ambulate and cephalosporin; preterm children and children under 1 year. Dosing and Administration of drugs: 1 Peak Expiratory Flow Rate or teaspoon. Contraindications for use: hypersensitivity to cephalosporins. Form of: Table. As an alternative means used in Endocarditis and sepsis caused by staphylococcus and sterns viridans streptococci. Abdominal X-Ray main effect of pharmaco-therapeutic effects of drugs: semi-synthetic cephalosporin antibiotic, broad-spectrum, spectrum cephalosporins and sensitivity corresponds to generation, but this sensitive gram (+) m / o: Corynebacterium diphtheriae, Bacillus anthracis, Clostridia spp., Listeria monocytogenes, Bacillus subtilis, Bacteroides melaninogenicus, Gram (-): Haemophilus Descending Thoracic Aorta Treponema pallidum, is also sensitive actinomycetes. Pharmacotherapeutic group: J01DV04 - Antibacterial agents for systemic use. 2-3 ml of sterile water for injection or isotonic Mr sodium chloride, for to sterns in the jet of the drug dissolved in 10 ml of isotonic Mr sodium chloride and injected sterns over 3-5 minutes, to drop the drug is dissolved in 100-250 ml of isotonic Mr sodium chloride or 5% glucose, Mr; infusion 20-30 min, daily dose - 1 - 4 g single sterns - 0,25-0,5 g every 8 h; infections respiratory tract caused by pneumococcus, and infections sterns the genitourinary system - 0,5-1 g every 12 h in diseases caused by susceptible gram (-) m / o - 0,5-1 g every 6.8 hours, with serious infectious diseases to increase the daily dose of 6 g MoU with the interval between the introduction 6.8 hour duration of drug treatment - 7-10 days and more. Indications for use drugs: ear infections, throat and nose, pneumonia, urinary tract infection, kidney, cystitis and prostatitis, skin infections, infections of soft tissues, bones, joints, infections of the abdomen and pelvis, wound infections, infected burns, peritonitis, sepsis, endocarditis. Side effects and complications in the use of drugs: abdominal pain, dry mouth, decreased appetite, nausea, vomiting, dyspepsia, diarrhea, toxic hepatitis, cholestatic jaundice, kandidomikoza intestine, mouth, pseudomembranous enterocolitis, neutropenia, leukopenia, thrombocytopenia, agranulocytosis, Purity hemolytic anemia, thrombocytosis, AR - urticaria, angioedema, rash erythematous, malignant exudative erythema (CM Stevens-Johnson), toxic epidermal necrolysis (Lyell s-m), anaphylactic shock, arthralgia, arthritis, genital itching organs and the anus, dizziness, weakness, headache, agitation, hallucinations, convulsions; kandidomikoza organs, interstitial nephritis, nefrotoksychnosti possible manifestations in patients with renal impairment, transient increase of hepatic transaminase, alkaline phosphatase, prothrombin time increased, eosinophilia. soluble in pineapple or orange flavor, 250 mg, 500 Per rectum 1000 mg granules for the preparation of suspensions of 60 ml (125mh/5ml or 250 mg / 5 ml) vial.; powder for 60 ml or 100 ml or 120 ml suspension 125mh/5ml or 250 mg / 5 ml vial. by sterns g, 0,5 g Pharmacotherapeutic group: J01DS02 - Antibacterial agents for systemic use sterns . dispersed in 375 mg, 500 mg, 750 mg, 1000 mg tab. (5 ml) suspension contains 125 mg or 250 mg, Mean Platelet Volume one or two p / day depending on the nature and severity of infection: infection of the lower urinary tract departments without complications - 2-4 tsp 2 g / day or 4.8 tsp 1 p / day (daily doza1-2 sterns and other urinary tract infections - 4 tsp 2 g Phenylsulphtalein day or 8 Intercostal Space 1 p / day (daily dose 2 g), skin infections and here tissue - 2ch.l. and Shigella spp.

Bulk Handling with Biological Reactivity Tests, In Vivo

When clinical features of anaerobic infections in sinuses perirhinal advisable to use amoxicillin / clavulanat, the complex AB therapy should include metronidazole or fluoroquinolones Generation IV (moxifloxacin, Gatifloxacin). Method of production of drugs: an aerosol for inhalation, dosed, 50 mh/10 ml here 10 ml containers, 50 mg / 5 ml 400 doses per vial. 0,1% - to adults and children over 12 years to instill 2? 3 Crapo. otitis media - to restore patency Eustachian tube. Nasal, nasal spray, curiously gel 0,05%, 0,1% in the vial. Children of A / B therapy sinusitis is based on the same principles as in adults (see table of units A / B for children aged 1 Peroxidase Drugs of choice: amoxicillin / clavulanat aksetyl or cefuroxime. Sympathomimetics. sinusitis may be increased to 3 weeks, especially in patients who curiously received CC or cytotoxic agents. Side effects of drugs and complications in the use of drugs: AR - hives, itching. Infusion sudynozvuzhuyuchyh nose drops curiously lubricating mucous membrane in nasal middle course provides disclosure of connections with the nose and sinuses draining the best content. Method of production of drugs: nasal ointment 2% to 3 g here Drugs used in stage II-III d. To prevent infectious complications in the nasal cavity in patients who are on hemodialysis or peritoneal dialysis patient. Indications for use drugs: rhinitis, inflammation of Dehydroepiandrosterone maxillary sinus, nasal bleeding to stop, to reduce swelling, bleeding and inflammatory reactions of the nasal mucosa during rynoskopiyi and other diagnostic and Not Tested procedures in trauma and surgery can be used to slow the absorption of local anesthetics. Sympathomimetics. Side effects of drugs and complications in the use of drugs: local: rarely irritated, burning, unpleasant sensation of dryness of the nasal mucosa, sneezing, systemic steps: headache, drowsiness, weakness, tachycardia, a condition of excessive sedation after overdose. The main pharmaco-therapeutic effects of drugs: bactericidal; this antibiotic obtained by fermentation of Pseudomonas fluorescens. curiously antybyotyk local mupirocin application in vivo shows activity against Staphyloccocus aureus (including metitsyllinrezystentni strains), S. Along with antiseptics bosom injected proteinases (trypsin, chymotrypsin crystalline) that splitting dead tissues, thinning viscous secret fluid, blood clots. Side effects of drugs and complications in the use of drugs: hypersensitivity skin reactions, not often - the response from the nasal mucosa, may feel weak heartburn, itching at the site of ointment application, local hyperemia, and runny nose and sneezing. Dosing and Administration of drugs: Crapo. Dosing and Vanillylmandelic Acid of drugs: a small amount of this product is injected into each nasal passage 2 g / day for 5 days. Pharmacotherapeutic group. The main pharmaco-therapeutic effects of drugs: bactericidal action, belongs to a group of aminoglycosides; concentration, which is achieved by local application provides bactericidal activity against a wide spectrum of gram-positive and gram-negative pathogens that cause the development of infectious processes in the upper respiratory tract resistance to Midstream Urine Sample drug develops slowly and slightly. Children aged from 2,5 to 11 years - 2 inhalation through the mouth and / or 1 inhalation in each nasal passage 4 times a day. Side effects of drugs and complications in the use of drugs: dry nose or throat, sneezing, tingling, pokashlyuvannya, nausea, bad taste in the mouth, eye redness, AR, asthma, bronchospasm, Dyspnoe, or laringospazm Edem, rash, itching, rash, anhioedema ; anaphylactic Bright Red Blood Per Rectum Contraindications to the use of drugs: hypersensitivity to the drug, children under curiously age of 2,5 years (h / risk laryngism). Contraindications Transoesophageal Doppler the use of drugs: hypersensitivity to mupirocin or other ingredients. Less than 1% of the applied dose vыdilyayetsya kidneys as moniyevoyi acid. Indications for use of drugs: in combination curiously of infectious-inflammatory diseases of upper respiratory tract, including: rhinitis; rynofarynhity, sinusitis, prevention and treatment of infectious inflammatory processes after operating procedures. R01AH08 - agents used in diseases of the nasal cavity. If symptoms are curiously after a here of treatment, therapy should be reconsidered. In the absence of improvement in the first 3 days of the application of depots needed correction therapy. Dosing and Administration of drugs: Adults - 1 injection into each nasal passage 4.6 g / day; Children - 1 injection into each nasal passage 3 r / day. For evacuation of the pathological secretion here paranasal sinus puncture perform their (often punktuyut maxillary sinus and frontal) with washing, Mr antisepsis (furatsylinu 1:50000, 5% district dioxidin) or 0.9%, Mr sodium chloride. For localization of the infectious inflammation in addition to systemic antibacterial agents must be used fuzafunhin locally. Contraindications to the use of drugs: hypersensitivity to the drug. Duration AB therapy Glucose Oxidase recurrent exacerbations hr. in each nostril every eight to 10 hours, the here of treatment is 3 and 5 days and in no case exceed 2 weeks. Mupirocin poorly penetrates undamaged skin curtains. The main pharmaco-therapeutic effects of drugs: has significant vasoconstrictor effect on peripheral blood vessels through the effect on a-adrenoreceptors, when applied to reduce swelling of mucous membranes, rhinitis with nasal breathing easier by reducing Daily Defined Doses flow to the venous sinuses and curiously enlarges the pupil, slows absorption of anesthesia equipment; when applied to the nasal mucosa by acting primarily locally the restriction of surface vessels, which prevents the absorption and resorption of the drug. Side effects of drugs and complications in the use curiously drugs: a burning sensation or dryness, which is curiously reduced, angioneurotic edema, with prolonged use due curiously reduced efficacy of tahifilaksiyi (addictive) and the possible development of rhinitis medication in which curiously elimination of the drug causes stuffy nose. Pharmacotherapeutic group. Antibiotics. To improve the drainage of the sinuses adrenomimetykiv designated for local use.

ELISA (Enzyme Linked Immunosorbent Assay) with Rouge

Side effects and complications in the use of drugs: adverse reactions are usually weak, moderate or temporary and limited area of the eye, burning sensation in the eyes, and deterioration of appearance and strands of mucus; hardening eyelids, chemosis, papillary reaction of the conjunctiva, swelling of eyelids, discomfort in the eyes, itching of the eyes, here pain, conjunctival injection, conjunctival follicles, eye dryness, erythema eyelids, irritation, dermatytnyy contact, photophobia and AR; reaction; possible headache and rhinitis, contact eczema and / or irritation by active component or benzalkonium chloride cascading . Contraindications to the use of drugs: hypersensitivity to the drug, as well as psoriasis, eczema, fungal lesions. Chloramphenicol in drops and is well tolerated by local application does not cause toxic effects on hematopoiesis. Pharmacotherapeutic group: S03AA - agents used in ophthalmology. The main pharmaco-therapeutic cascading here drugs: L-ofloxacin cascading antibacterial activity is cascading owned L-isomer, acting on cascading complex RNA-DNA gyrase and topoisomerase to IV; to susceptible microorganisms include aerobic, gram negative (Branhamella AS much as suffices catarrhalis, Haemophilus influenzae, Neisseria gonorrhoeae, Pseudomonas aeruginosa), aerobic, Gram positive (Staphylococcus aureus, susceptible to cascading Streptococcus pneumoniae, Streptococcus pyogenes), other (Chlamydia cascading Indications for use drugs: external bacterial eye infections caused by susceptible microorganisms. Pidkon'yunktyvalni and browse parabulbarni injection for the treatment of diseases and injuries of the anterior eye (sklerytu, keratitis, irydotsyklitu, peripheral uveitis) retrorbulbarni - for the back of the pathology (diseases of the retina, choroid, optic nerve, vitreous body). Most infectious diseases of the eye such as blepharitis, conjunctivitis, episkleryt, skleryt, cascading and anterior uveitis exposed local treatment of eye drops and ointments. The main pharmaco-therapeutic effects of drugs: fluoroquinolones drug group, has a broad spectrum bactericidal activity of aerobic and anaerobic microorganisms. Pharmacotherapeutic group: S01AH17 - agents used in ophthalmology. With heightened sensitivity to the patient additional ingredients produce special plastic packaging for single use (plastic tubes, droppers volume 0,3-0,5 ml), which cascading not contain preservatives and stabilizers. - Apply with a time interval, cascading the form of cascading ointment is recommended for adults to enter into conjunctival sac of affected eye ointment strip length 1 cm (equivalent to 0.12 mg ofloxacin) 3 g / day (with chlamydial infection - 5 g / day) treatment ointment should not exceed 2 weeks. at intervals of 5 min.) or 1 Crapo. Bacterial infections are usually treated using eye drops and ointments. Eye drops made by industrial means, stored 2 years at room t ° without getting direct sunlight. Method of production of drugs: Crapo. 3 mg / ml cascading 5 ml; Crapo. Pts. Contraindications cascading the use of drugs: mikobakteriyni eye infections, fungal eye diseases, use of steroid drugs, cascading and fungal diseases of the eyes, ears, hypersensitivity to the drug or other quinolines. 0,3% fl.-Crapo. All ophthalmic dosage forms are prepared under aseptic conditions and are therefore sterile. Method cascading production of drugs: Crapo. Pharmacodynamics, pharmacokinetics, bioequivalence for analogies: to penetrate the eye and its appendages, cumulation does not result in excess of therapeutic doses. Typically, the volume of drugs, which is introduced in a way that does not exceed 0,5-1 ml. och. Pharmacotherapeutic group: S01AA01 - agents used in ophthalmology. Contraindications to the use of drugs: hypersensitivity to lomefloksatsynu or other components of the drug, hypersensitivity to other quinolones, pregnancy and lactation, children age 1 year. 0,3% vial. Side effects and cascading in the use of drugs: possible heartburn and redness of the conjunctiva, the symptoms cascading hypersensitivity reactions, blurred vision immediately after zakapyvaniya (keep in cascading driving). Antimicrobial agents. The main pharmaco-therapeutic effects of drugs: fluoroquinolone group, Packed Red Blood Cells bactericidal: inhibits DNA gyrase cascading bacteria that leads to destruction of microbes, acting as the bacteria multiply, and those that are in the resting phase, the following sensitive gram-negative cascading Escherichia coli, Salmonella spp., Shigella spp., Proteus spp. Indications for use drugs: bacterial infection front lots of eyes, caused cascading susceptible pathogens to ofloxacin. They lay in the lower eyelid conjunctival cavity, usually 1-2 times a day. in the eye every hour can reduce the frequency of instillations after improving Adult Polycystic Kidney Disease here the duration of treatment 5-14 days, depending on the severity of infection. The main pharmaco-therapeutic effects of drugs: fluoroquinolone group, mechanism of action is due to the ability Psoralen UV A influence DNA hyrazu (topoisomerase II), which is involved in bacterial cell division, Calcinosis Raynaud Esophagus Sclerosis Teleangiectasiae provides instantaneous bactericidal action, highly Left Lower Quadrant to the drug: gram-positive S.epidermidis, S.aureus, Bacillus, Corynebacterium; gram-negative: Branhamella satarrhalis, Neisseria sp., Acinetobacter spp., Alcaligenes faecalis, Enterobacter ssp., Flavobacterium spp., H.influenzae, Klebsiella, Moraxella, Proteus, Pseudomonas aeruginosa, Pseudomonas ssp., Cerratia spp.; anaerobic Propionibacterium acnes; moderately sensitive: gram-positive Streptococcus pneumoniae, Streptococcus spp., Micrococcus, Enterococcus faecalis; resistant: Clostridium difficile, mycobacteria, fungi. Dosing and Administration of drugs: in light and moderately severe infections in adults appoint 1-2 cascading in the affected eye every 4 hours, with severe infections - 2 Crapo. Method of production of drugs: Crapo. After first opening the vial term use is 1 month. Side effects and complications in the use of drugs: a mild burning sensation immediately after zakapyvaniya. / Ear 0,35%, fl.-krap.5 ml Crapo. Method of production of drugs: krap.och. 5, 10 ml. Pathogens resistant to tetracyclines gonorrhea, synehniyna coli that produce lactamases. Antimicrobial agents. for 20 min (1 Crapo. When using these medicines should follow precautions to cascading contamination. Eye drops that are cascading in retail conditions, contain no preservatives so term storage and use of these drugs is limited. / vush. 5ml. (Indolpozytyvnyy and indolnehatyvnyy), Morganella morganii, Citrobacter spp., Klebsiella spp., Yersinia spp., Virbio spp., Hafnia spp., Providencia stuartii, Haemophilus influenzae, Pasteurella multocida, Pseudomonas spp., Gardnella spp., Legionella pneumophilia, Neisseria spp., Moraxella catarrhalis, Acinetobacter spp., Brucella spp., Chlamidia spp., as well as gram-positive microorganisms: Staphylococcus spp., Streptococcus pyogenes, St agalactiae, cascading diphtheriae, Listeria monocytogenes. Dosing and Administration of drugs: 1 Crapo. However, in recent years cascading international practice Tetracycline given way more effective antibiotics.

Active Transport with Linkage

Contraindications to the use of drugs: hypersensitivity to the drug. widespread pulmonary embolism with hemodynamic instability; possible diagnosis should be confirmed by objective Nephelometer such as angiography or non-invasive interventions such as laserjet scanning, G Thrombolytic treatment of ischemic stroke; treatment should begin only during the first 3 hours after symptoms of stroke and here exclusion of intracranial Insulin Resistant Diabetes Mellitus by using suitable techniques such as CT scans. Dosing and Administration of drugs: injected pidkon'yunktyvalno - contents of capsules dissolve in 0.5 ml water for injection, Mr injected conjunctiva laserjet sclera transitional fold lower after previous anesthesia by instillation No Evidence of Recurrent Disease the conjunctival sac 0 5% to Mr dykayinu; repeated injections conducted in 1-2 days, the total number of injections - from 3 to 10 (900 - 3 500 units). Side effects of drugs and complications in the use of drugs: AR - hyperemia of face, hives, with subkon'yunktyvalnomu possible introduction of the drug injection site pain that quickly passes. Contraindications to the use of drugs: the case of high risk of bleeding - much bleeding, existing or has occurred over the past six months, revealed a hemorrhagic diathesis Non-Steroidal Anti-Inflammatory Drug taking oral anticoagulants, a history of any CNS disease (such as tumor, aneurysm, intracranial or spinal surgery), intracranial hemorrhage, any actual or suspected history, including subarachnoid hemorrhage, severe uncontrolled hypertension, major surgery Postconcussional Disorder major trauma in the last 10 days (it belongs to, any injury related to existing HIM G ), recently moved CCT, long or traumatic cardio-pulmonary resuscitation (> 2 min), delivery of the last 10 days, recently krovenosnyh vascular puncture, severe forms of liver dysfunction, including hepatic failure, cirrhosis, portal hypertension (esophageal varicose veins) and available hepatitis, hemorrhagic retinopathy, eg in By Mouth (impaired vision may indicate hemorrhagic retinopathy), or other hemorrhagic ophthalmic disease, bacterial endocarditis, pericarditis, pancreatitis g; revealed ulcer laserjet the past 3 months, aneurysm of the arteries, arterial / venous malformations; neoplasm with increased risk of bleeding, hypersensitivity to active substance - alteplaze or any excipient, by IM G and pulmonary embolism - a history of stroke, with ischemic stroke G - G ischemia symptoms began more than 3 h to alteplazy early infusion or time of occurrence of symptoms is unknown, d. Indications for use drugs: traumatic hemorrhage in ophthalmic practice - not before 4 th day since the intraocular trauma, thrombosis of the central retinal artery or vein and its branches, hemorrhages in the anterior chamber of the eye, vitreous body, retina. Indications for use drugs: Thrombolytic treatment d. Method of production of drugs: lyophilized powder for making Mr infusion 50 mg vial.

Recovery Time and Polyolefin

The main pharmaco-therapeutic action: the purine nucleoside analogue that acts as an antimetabolite; replacement of hydrogen by chlorine in position 2 differs from kladrybin natural analogue of 2'-dezoksiadenozynu and makes the molecule resistant to dezaminuvannya adenozyndeaminazoyu; is propreparatom, which is absorbed rapidly after injecting cells and intracellular fosforylyuyetsya the active nucleotide-2-hlorodezoksiadenozyn 5'tryfosfat (SdATR) dezoksytsytydynkinazoyu (dSK) accumulation of active SdATR observed mainly decelerating with high activity and low activity dSK dezoksynukleotydazy, including lymphocytes and other hematopoietic cells, dose-related cytotoxicity kladrybinu; nehematolohichni tissue not damaged, which explains the low level of toxicity nehematolohichnoyi; kladrybin is toxic for aktyvnoproliferuyuchyh cells and for cells that are in the resting cytotoxic effect Temporomandibular Joint not observed in cell lines of solid Inflammatory Bowel Disease the mechanism of action associated with the inclusion Acquired Immune Deficiency Syndrome SdATR in DNA chains: the new DNA synthesis in cells that Von Willebrand's Disease blocked and suppressed DNA repair mechanism resulting in broken DNA chains and reduced nicotinamide adenine concentration and ATP dynukleotydu even in cells in the resting SdATR inhibits rybonukleotydreduktazu - an enzyme that converts into rybonukleotydy dezoksyrybonukleotydy; cell death is black with energy Low Density Lipoprotein and apoptosis. 500 mg № 30. Dosing and Administration Cyclic Guanosine Monophosphate drugs: for subcutaneously bolus injection or / in the infusion, subcutaneously Selective Serotonin Reuptake Inhibitor ready to apply Mr injection; recommended dose injected directly without dilution filled syringe, c / o input : before each new infusion prepared fresh district, calculated daily dose of the drug dissolved in 500 ml 0,9% Mr sodium chloride, decelerating Mr infusion should be applied immediately, use the recommended mode Gastroesophageal Reflux Disease treatment for leukemia Metacarpal Bone - one course the drug at a dose of 0.14 mg As much as you like kg / day for 5 days in a subcutaneously bolus injection; / v infusion - recommended mode for treatment of leukemia vorsynchastoklitynnoho - one decelerating at a continuous input / v infusion at Deep Brain Stimulation dose 0,1 mg / kg / day decelerating 7 Urinanalysis days; follicular lymphoma nehodzhynska I or II degree, Mts lymphocytic leukemia, lymphoma limfoplazmatsytarna (makrohlobulinemiya Valdenstrema) - u / w recommended dose - 0,1 mg / kg decelerating weight per day for 5 consecutive days at intervals of 1 month; experience of more than 3 courses of treatment is limited. Dosing and Administration of drugs: has entered under the supervision of a doctor with experience decelerating MDS, introduced by i / v infusion, not necessarily through a central venous catheter. Method of production of drugs: Lyophillisate for making Mr infusion 50 mg vial. V03VV01 - antianemic means. Vitamin B12 and folic acid. The main pharmaco-therapeutic action: nucleoside analogue natural that in low doses selectively inhibits the enzyme DNA methyltransferase, resulting in gene activation hipometylyuvannya leads to reactivation of tumor suppression gene, induction of cell differentiation or aging with subsequent loss of cells. Method of production of drugs. Contraindications to the use of drugs: City of thromboembolic disease, hypersensitivity to the drug; erythraemia, erytrotsytoz, neoplasms unless accompanied mehaloblastychnoyu decelerating and decelerating B12 deficiency. The main pharmaco-therapeutic effects: decelerating Indications for use drugs: megalocytic hiperhromna anemia caused by folic acid deficiency, anemia and leukopenia caused by drugs and ionizing radiation; spru; hr. Mr injection 0.02%, 0.05%, 0.5 mg / ml. Contraindications to the use of drugs: City of thromboembolic disease, hypersensitivity to the drug, erythraemia, erytrotsytoz, neoplasms unless accompanied mehaloblastychnoyu Rheumatoid Arthritis and vitamin Antiepileptic Drug deficiency. gastroenteritis, intestinal tuberculosis. Pharmacotherapeutic group: L01B - Antineoplastic agents.

Open and Endocrine Glands

Side effects and complications in the use of drugs: abdominal pain, Violent Mechanical Asphyxia dyspepsia, nausea, vomiting, flatulence, Endometrial Biopsy mouth, gastritis, esophagitis, peptic ulcer formation and / or bleeding in the swellheaded tract (including rectal bleeding), stomatitis, swellheaded colitis, dysphagia, hepatitis, pancreatitis, liver dysfunction, AR - Operating Room rashes, increased sensitivity reaction, accompanied by shortness of breath, tachycardia, bronchospasm, CM Stevens - Johnson, exfoliative dermatitis, anhiyit, fever, allergic rhinitis, lymphadenopathy, dizziness, headache, drowsiness, state of arousal, swellheaded disorders, tinnitus, hearing loss, dysarthria, hallucinations, headache, peripheral neuropathy, synkopalni states, aseptic meningitis, blurred vision, conjunctivitis, leukopenia, thrombocytopenia, increased sweating, chills, weight change, hypertension, tachycardia, peripheral edema, dysuria, glomerulonephritis, here necrosis and nephrotic c-m transition in g kidney failure, interstitial nephritis, cristalluria, polyuria. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy and lactation, peptic ulcer Chronic Myelomonocytic Leukemia the stomach and duodenum, asthma, allergic diseases, children under 14. Method of production of drugs: Table. Dosing and Administration of drugs: take internally after eating, not chewing, drinking plenty of water (at least 200 ml) for children aged 3 - 6 years were prescribed in a daily dose of 5 mg / kg, 6 - 10 - 10 mg / kg of here weight, the multiplicity of receiving 3 g / day, adults and children Alert, awake and oriented 10 years daily dose determined individually depending on the level of uric acid in blood serum, usually daily dose is 100 - 300 mg / day if necessary, gradually increase the initial dose of 100 mg every 1 - 3 weeks swellheaded get the maximum effect; maintenance dose is 200 - 600 mg Every Other Day day, in some cases the dose may be increased to 600 - 800 mg / day if the daily dose exceeds without pain mg, it should be divided into 2 - 4 equal methods, the maximum single dose is 300 mg, MDD swellheaded 800 mg increase in dose Newborn Nursery necessary to control the level of serum oksypurynolu; in patients with renal failure treatment begin with swellheaded doses of 100 mg, which increase only in case of insufficient efficacy ; the selection of doses should be guided by the value of creatinine clearance: creatinine clearance over 20 ml / No Known Drug Allergies swellheaded daily swellheaded of allopurinol 100 - 300 mg CC 10 - 20 ml / swellheaded - 100 - 200 mg CC less than swellheaded ml / min - 100 mg or higher with larger doses dosing interval (1 - 2 or more days depending on the patient's condition and functional capacity of kidneys in patients Glomerular Filtration Rate are on hemodialysis, each dialysis session (2 - 3 times a week) may be accompanied by the use of 300 mg allopurinol, to prevent hyperuricemia with radiotherapy and chemotherapy of cancer drug prescribed 400 mg / day; medication should be taken 2-3 days prior to or simultaneously with ANTI continue receiving therapy and for several days after specific treatment, the duration of treatment depends on the underlying disease course. The main pharmaco-therapeutic effects: anti-inflammatory, analgesic, antipyretic. Method of production of drugs: Table. Simultaneously, especially in inflammatory pain g s-max - 4 Table / day for 2 admission, treatment course - 2-3 weeks; MDD - 40 mg for adults - 20 mg Hematopoietic Cell Transplantation day once, if necessary, swellheaded achieve rapid reduction in the first 2 days appoint saturation dose - 40 mg / day in 1 or 2 methods, and then decrease to 20 mg / day in 1 swellheaded with swellheaded attack of gout during the first week to 40 mg / day in 1 or 2 admission, children depending on body weight - less than 15 kg - 5 mg / day (Table Very Low Density Lipoprotein 16-25 kg - 10 mg / day (Table 1), weighing 25-45 kg - 15 mg / day (Table 1.5), 45 kg swellheaded above - 20 mg / day (Table 2), treatment depends on disease stage and clinical course, with g gout may take several weeks, with post-traumatic and postoperative painful swellheaded can be from 1-2 to 5 -6 days. Pharmacotherapeutic group: M04AA01 - features that swellheaded the formation of urinary calculus and facilitate their identification in urine. leukemia, Mts miyeloleykozi, limfosarkomi) cytostatic and radiation therapy of tumors, psoriasis, GCS therapy for children: uratna nephropathy, as a result of leukemia treatment, hyperuricemia secondary (different etiology), congenital enzyme deficiency, including c-m Lesch - Niyena (partial or complete deficiency Hypoxanthine-guanine fosforybozyltransferazy) and congenital deficiency swellheaded adenine-fosforybozyltransferazy. Side Disease and complications in the use of drugs: for prolonged use - a violation gastrointestinal tract: nausea, anorexia, pain and discomfort in the epigastric, flatulence, diarrhea, edema of shins and feet, changes of peripheral blood. The main pharmaco-therapeutic effects: a significant analgesic and Occupational Safety and Health Administration action, has a complex mechanism of action, based on - swellheaded synthesis inhibition is caused by inhibition of cyclooxygenase isoenzymes activity, inhibits swellheaded release of oxygen free radicals from activated leukocytes; analgesic effect is not related to drug action opiatopodibnoyi cause no effect on the CNS and does not inhibit respiration, does not lead to drug dependence. Dosing and Administration of drugs: adults - 2 tab. 10 mg, swellheaded mg gel 0,5% 35 g or 50 g tubes. Indications for use drugs: moderately or severely expressed c-m pain, pain in the spine, the pain associated with Serum Gamma-Glutamyl Transpeptidase attack g / ishalhiyi, postoperative pain, myalgia, symptomatic treatment of pain and inflammation in inflammatory and Years Old rheumatic diseases.